Proprietary Hydrogel Biosensor Platform: Profusa holds unique, patented technology for tissue-integrated biosensors, differentiating it from traditional monitoring methods.

Extended Continuous Monitoring Capability: Their technology enables stable, long-term (months to years) continuous monitoring of biomarkers directly from the interstitial fluid.

Minimally Invasive Implantation Method: The small, injectible biosensor offers a less intrusive solution compared to repeated blood draws or some other wearable devices.